Background The prognosis of synovial sarcoma (SS), an aggressive soft tissue sarcoma, remains poor. respectively. TAS-115 treatment blocked the phosphorylation of PDGFR as well as that of c-MET and their downstream effectors, leading to marked growth inhibition in both types of SS cell lines in in vitro and in vivo studies. Furthermore, PDGFR phosphorylation, on… Continue reading Background The prognosis of synovial sarcoma (SS), an aggressive soft tissue